137 related articles for article (PubMed ID: 37914255)
21. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
[TBL] [Abstract][Full Text] [Related]
22. A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets.
Breen V; Kasabov N; Kamat AM; Jacobson E; Suttie JM; O'Sullivan PJ; Kavalieris L; Darling DG
BMC Med Res Methodol; 2015 May; 15():45. PubMed ID: 25962444
[TBL] [Abstract][Full Text] [Related]
23. Assessment of a clinical pathway for investigation of haematuria that reduces the need for cystoscopy.
Davidson PJ; McGeoch G; Shand B
N Z Med J; 2020 Dec; 133(1527):71-82. PubMed ID: 33332329
[TBL] [Abstract][Full Text] [Related]
24. Urinary biomarkers in bladder cancer: where do we stand?
Bhat A; Ritch CR
Curr Opin Urol; 2019 May; 29(3):203-209. PubMed ID: 30855372
[TBL] [Abstract][Full Text] [Related]
25. Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.
van Kessel KE; Beukers W; Lurkin I; Ziel-van der Made A; van der Keur KA; Boormans JL; Dyrskjøt L; Márquez M; Ørntoft TF; Real FX; Segersten U; Malats N; Malmström PU; Van Criekinge W; Zwarthoff EC
J Urol; 2017 Mar; 197(3 Pt 1):590-595. PubMed ID: 27746284
[TBL] [Abstract][Full Text] [Related]
26. Microhematuria: AUA/SUFU Guideline.
Barocas DA; Boorjian SA; Alvarez RD; Downs TM; Gross CP; Hamilton BD; Kobashi KC; Lipman RR; Lotan Y; Ng CK; Nielsen ME; Peterson AC; Raman JD; Smith-Bindman R; Souter LH
J Urol; 2020 Oct; 204(4):778-786. PubMed ID: 32698717
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation.
Rodgers M; Nixon J; Hempel S; Aho T; Kelly J; Neal D; Duffy S; Ritchie G; Kleijnen J; Westwood M
Health Technol Assess; 2006 Jun; 10(18):iii-iv, xi-259. PubMed ID: 16729917
[TBL] [Abstract][Full Text] [Related]
29. [The evaluation of cystoscopy in the screening of asymptomatic microhematuria].
Hattori R; Matsuura O; Takeuchi N; Hashimoto J; Ohshima S; Ono Y; Yamada S; Kinukawa T; Miyake K
Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):810-5. PubMed ID: 1875575
[TBL] [Abstract][Full Text] [Related]
30. Assessment of Diagnostic Yield of Cystoscopy and Computed Tomographic Urography for Urinary Tract Cancers in Patients Evaluated for Microhematuria: A Systematic Review and Meta-analysis.
Waisbrod S; Natsos A; Wettstein MS; Saba K; Hermanns T; Fankhauser CD; Müller A
JAMA Netw Open; 2021 May; 4(5):e218409. PubMed ID: 33970257
[TBL] [Abstract][Full Text] [Related]
31. Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis.
Chou R; Gore JL; Buckley D; Fu R; Gustafson K; Griffin JC; Grusing S; Selph S
Ann Intern Med; 2015 Dec; 163(12):922-31. PubMed ID: 26501851
[TBL] [Abstract][Full Text] [Related]
32. Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.
Schmitz-Dräger C; Bonberg N; Pesch B; Todenhöfer T; Sahin S; Behrens T; Brüning T; Schmitz-Dräger BJ
Urol Oncol; 2016 Oct; 34(10):452-9. PubMed ID: 27381893
[TBL] [Abstract][Full Text] [Related]
33. Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A Physician-Patient Real-World Clinical Data Analysis.
Lough T; Luo Q; O'Sullivan P; Chemaslé C; Stotzer M; Suttie J; Darling D
Oncol Ther; 2018 Jun; 6(1):73-85. PubMed ID: 32700139
[TBL] [Abstract][Full Text] [Related]
34. Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer.
Parekattil SJ; Fisher HA; Kogan BA
J Urol; 2003 Mar; 169(3):917-20. PubMed ID: 12576812
[TBL] [Abstract][Full Text] [Related]
35. Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non-Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013.
Bree KK; Shan Y; Hensley PJ; Lobo N; Hu C; Tyler DS; Chamie K; Kamat AM; Williams SB
JAMA Netw Open; 2022 Mar; 5(3):e223050. PubMed ID: 35302627
[TBL] [Abstract][Full Text] [Related]
36. Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study.
Kavalieris L; O'Sullivan P; Frampton C; Guilford P; Darling D; Jacobson E; Suttie J; Raman JD; Shariat SF; Lotan Y
J Urol; 2017 Jun; 197(6):1419-1426. PubMed ID: 27986532
[TBL] [Abstract][Full Text] [Related]
37. Bladder cancer risk stratification using a urinary mRNA biomarker panel - A path towards cystoscopy triaging.
Shkolyar E; Zhao Q; Mach KE; Teslovich NC; Lee TJ; Cox S; Skinner EC; Lu Y; Liao JC
Urol Oncol; 2021 Aug; 39(8):497.e9-497.e15. PubMed ID: 33766467
[TBL] [Abstract][Full Text] [Related]
38. NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer.
Zippe C; Pandrangi L; Potts JM; Kursh E; Novick A; Agarwal A
Anticancer Res; 1999; 19(4A):2621-3. PubMed ID: 10470205
[TBL] [Abstract][Full Text] [Related]
39. Urinary tissue polypeptide-specific antigen for the diagnosis of bladder cancer.
Sánchez-Carbayo M; Urrutia M; Silva JM; Romaní R; García J; Alférez F; González deBuitrago JM; Navajo JA
Urology; 2000 Apr; 55(4):526-32. PubMed ID: 10736496
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic yield of repeat evaluation for asymptomatic microscopic hematuria after negative initial workup.
Pak JS; Wang EY; Lee K; Pina LA; McKiernan JM; Anderson CB
Urol Oncol; 2021 May; 39(5):300.e1-300.e6. PubMed ID: 33339726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
